| Tag | Content |
|---|
EnhancerAtlas ID | HS010-03038 |
Organism | Homo sapiens |
Tissue/cell | B_cell_blood |
Coordinate | chr3:40664910-40665680 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| KLF4 | MA0039.3 | chr3:40665335-40665346 | CCACACCCTCT | + | 6.02 | | MEF2A | MA0052.3 | chr3:40665200-40665212 | GCTATAAATAGC | + | 6.32 | | MEF2B | MA0660.1 | chr3:40665200-40665212 | GCTATAAATAGC | + | 7.22 |
|
| | Number of super-enhancer constituents: 2 | ID | Coordinate | Tissue/cell |
| SE_10708 | chr3:40664352-40667985 | CD19_Primary | | SE_11768 | chr3:40663906-40668485 | CD20 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH03I040623 | chr3 | 40664645 | 40667157 |
|
Enhancer Sequence | GGGAGATACC AGGATCATTA ACACACATTT TCTGTTTTCT GGCAGCCCAA CACCTCATGG 60
GAAGGTCTGG CTTGTAGTTT AACTGATGGT GTATAGTAGG TGCTCAGTTG CCTGTTTGGT 120
CCTTTCTCTC TTCTTGATCA CCCCTTTCCT CTCTGGCTCC CACATATGGT TCAAAACCTG 180
AACACACACA TTGGCCTGCT CCTCTTCTGG CTCACAAGAG AAATGAATTG GCTGGCAGGA 240
GACCAGTATC CACCTGATGA AGCAATAAAC CATGTGGCAT GTAGATATTG GCTATAAATA 300
GCTTCCCTTC ATTATCTCCT CACTCAAAGC CCTTGCCTTT GAGTACCACG TCATCCCTTG 360
GTGCTGACAC ACCCAAACCA AAGCCAGTCT CCCTAGCAAC TGAACCACAG TCAGTGGTGG 420
TCTGACCACA CCCTCTCATG GTTGGCAACC ATGCACAGTT CCTCATTTTA TTTCTGCTGC 480
AGGACAGGTT GGCTACTGGC TGATCTTTGG AACTAGAAAC ATCATTTTGC TCCTTAAATG 540
ATTAAAAAAG GCACACATGG GGCTTCTTTG TGTTAGTTCT TTTGTATCTC CATATCCTGT 600
CCCTGCATGG ATTATTTTGG TGCATGCTGC AGACTTGTTT TTGGAACTTG AATCCTGAGC 660
AAGTGAGAAG ACTTACTGGA TGCTGTTCAA GGCTCTGCAT GACAAACCTT GCACAAATAC 720
AAGGTATGAT TGCCACTGAC AGGGAGGATC ATGAGCTAGC TGGGATGTAG 770
|
